Speakers
Invited Speakers
Awards
Young Investigator Encouragement Award
The Young Investigator Encouragement Award recognises work performed by trainees in the Asia and Oceania region and presented in a platform and/or poster session at the 13th Asian Oceanian Congress of Neurology and the Australian and New Zealand Association of Neurologists Annual Scientific Meeting 2012.
Applicants for this Award must be under 35 years of age and are required to submit an abstract via online submission and select the Young Investigator Encouragement Award presentation preference to be considered for this Award.
Successful applicants will be eligible for a Travel Grant to assist with their travel costs to attend the Congress.
James W Lance Young Investigator Award
The James W Lance Young Investigator Award recognises work performed during pursuance of a higher degree and presented in a platform and/or poster session at the 13th Asian Oceanian Congress of Neurology and the Australian and New Zealand Association of Neurologists Annual Scientific Meeting 2012.
Applicants for this Award must be current members of ANZAN. Applicants are required to submit an abstract via online submission and select the James Lance Young Investigator presentation preference to be considered for this Award.
James G McLeod Advanced Trainee Award
The James G McLeod Advanced Trainee Award recognises work performed during the clinical years of advanced training and presented in a platform and/or poster session at the 13th Asian Oceanian Congress of Neurology and the Australian and New Zealand Association of Neurologists Annual Scientific Meeting 2012.
Applicants for this Award must be current members of ANZAN. Applicants are required to submit an abstract via online submission and select the James McLeod Advanced Trainee presentation preference to be considered for this Award.
Yi-ning Huang, China
Professor Yi-ning Huang is Chairman of the Department of Neurology, First Affiliated Hospital of the Peking University, Beijing, China. He was trained at Peking Union Medical University, graduating in 1987. From 1990 to 1991, Professor Huang attended Salpetiere Hospital in Paris, France for advanced study, while at the same time holding a position in the department of neurology at Peking Union Medical College Hospital, where he went on to hold the post of Professor. In 2003, Professor Huang accepted his current position at Peking University First Hospital.
Professor Huang is one of the top stroke neurologists in Asia. He pioneered the work on transcranial Doppler and intracranial atherosclerosis research in China. He has been a principal investigator for a range of studies covering areas such as transient ischaemic attack, cerebral arterial stenosis, atherosclerosis, and secondary prevention of stroke. He has authored over 100 peer-reviewed articles, including Lancet Neurology, Stroke and Neurology etc. He is also the current Chairman of the Asia Stroke Advisory Panel.
Jianping Jia, China
Dr. Jia is the director and a professor in department of neurology at Xuan Wu Hospital of the Capital Medical University. He is currently the chairman of Chinese Neurologist Association, president of Neurology Committee of Chinese Medical Association, and president of China Cognitive Impairment and Dementia Association.
Dr. Jia mainly served the clinical work in neurology. His department includes more than 110 neurologists and 150 nurses, with 200 beds and average 2000 outpatients per day. Dr Jia research interests focus on mild cognitive impairment, vascular cognitive impairment, and Alzheimer's disease. He published more than 562 papers in which 82 is Science Citation Indexed, and the rest is in Chinese, and 6 textbooks, and 12 medical books.
Jong S Kim, Korea
Jong S. Kim. MD, PhD is currently a Professor of Neurology, University of Ulsan, and the Director, Stroke Center, Asan Medical Center. He graduated from Seoul National University and once worked at the Stroke Center, Henry Ford Hospital, Detroit, USA. He has authored 12 books and published 345 peer reviewed research papers. He is the founding editor of Journal of Clinical Neurology and currently the Chief Editor of Korean Journal of Stroke and an associate editor of International Journal of Stroke, and Cerebrovascular Dis. Extra, and an editorial board member of Stroke, Cerebrovascular Diseases, Neurocritical Care and European Neurology.
Satoshi Kuwabara, Japan
Professor & Chairman, Department of Neurology, Chiba University, Chiba, Japan
November 2008 (to date).
Education:
Graduated Chiba University School of Medicine in 1984.
Learned neurophysiology at the Prince of Wales Hospital, Sydney, in 1999-2000
Associate Editor: Journal of Neurology, Neurosurgery, and Psychiatry
Editor: Internal Medicine (Official Journal of Japanese Association of Internal Medicine)
Editorial Board: Clinical Neurophysiology
Cochrane-Database Systematic Review, Chief reviewer of "Treatment for POEMS syndrome"
Expertise: Neuroimmunology, Clinical neurophysiology,
Ming Liu, China
Ming Liu is a professor of neurology and Deputy Director of the Department of Neurology at the West China Hospital, Sichuan University, China and is Deputy Director of the Chinese Cochrane Centre and Chinese Centre of Evidence Based Medicine. She graduated from West China School of Medicine, West China University of Medical Sciences. She was a visiting scholar in Universities of Edinburgh, Oxford and London from 1995 to 1997. She is a member of the board of directors for the World Stroke Organization (WSO) and member of WHO Cerebrovascular Diseases Working Group. She is a Vice-President of the Chinese Stroke Society and a standing committee member of the Chinese Neurological Society. Her research work mainly related to clinical features of Chinese stroke patients, stroke register, randomized trials and systematic reviews of therapies from China, and stroke guideline development. She has published 190 papers in peer-reviewed journals. Her research work on stroke got the First Award of Ministry of Education in 2009 and CMWA Wuzhou Women Science & Technology Award in 2010.
Man Mohan Mehndiratta, India
Dr. Man Mohan Mehndiratta is currently Director-Professor in the Department of Neurology, G.B.Pant Hospital, Delhi University, New Delhi-India. He is a clinical neurologist and a researcher with teaching experience of more than 30 years.
He has published more than 150 scientific articles and chapters. He is a fellow of Royal College of Physicians (London, Glasgow and Edinburgh), Cochrane Neuromuscular Group, WHO fellow Critical Care Neurology, Indian Academy of Neurology and Indian College of Physicians.
He is a recipient of Ambassador of Epilepsy Award, A.B.Baker Teacher Recognition award AAN, Donald M. Palatucci Advocacy Advisor (2009) and Advocate (2008) of AAN, Netaji oration award and Prestigious Delhi State Award
He is currently President-Elect Indian Academy of Neurology, President-Indian Stroke Association, Secretary-General Asian Oceanian Association of Neurology and Co-Chair-Public Action Advocacy Task Force WFN
Teeratorn Pulkes, Thailand
Teeratorn Pulkes, originally from Bangkok, Thailand, graduated and did his Neurology training at the Ramathibodi Hospital, Mahidol University. He then went to UK for studying diploma course in Neurology and PhD in Neurogenetics at the Institute of Neurology, Queen Square during 1997-2001. He was awarded Pat Harris prize for the best candidate of the Diploma course in 1998. After training in UK, He has worked as a lecturer and consultant neurologist at the Ramathibodi Hospital in Bangkok.
Dr. Pulkes currently is an associate professor in neurology. His research interest is on epidemiology and clinical aspects of neurogenetic diseases, genetics of Parkinson's disease and mitochondrial DNA disorders.
Kurupath Radhakrishnan, India
Professor Kurupath Radhakrishnan is currently the Director of the Sree Chitra Tirunal Institute for Medical Sciences and Technology, and In-Charge of the R. Madhavan Nayar Center for Comprehensive Epilepsy Care at Trivandrum, Kerala, India. He did Fellowships in Neuroepidemiology, EEG and Epilepsy at the Mayo Clinic, Rochester, MN, USA. Dr. Radhakrishnan is a Fellow in Indian Academy of Medical Sciences and American Academy of Neurology, and a Member of American Neurological Association. In addition, he is a Life Member of Neurological Society of India, Indian Epilepsy Association, Indian Epilepsy Society and Indian Academy of Neurology. For additional information, visit http://www.sctimst.ac.in
Louis Tan, Singapore
Dr Louis Tan is a Senior Consultant Neurologist with the National Neuroscience Institute, Singapore (TTSH campus) and also the Co-Director of the Parkinson's Disease and Movement Disorders Centre there. In 2006, the Centre received the distinction of being an International Centre of Excellence for the United States based National Parkinson Foundation (NPF) for Parkinson-related research, comprehensive care and community outreach. He is an Adjunct Associate Professor of Duke-NUS Graduate Medical School, Singapore.
He is the President-elect of the Asian and Oceanian Section of the Movement Disorder Society. He is currently the Chair of the MDS Education Committee.
Upon graduating from the National University of Singapore and completing his neurology training at Tan Tock Seng Hospital, he underwent a movement disorders fellowship at the Parkinson's Institute in Sunnyvale, California.
His areas of specialty and research interests are Parkinson's disease and movement disorders. He is also interested in the interested in the epidemiology, clinical studies and clinical trials in Parkinson's disease and other movement disorders.
Ching-Piao Tsai, Taiwan
Professor Ching-Piao Tsai is Section Chief of the Neurological Institute at Taipei Veterans General Hospital, and National Yang-Ming University, Taipei, Taiwan. He is also Clinical Professor at the National Defense Medical School, Taiwan.
Prof. Tsai graduated with his MD degree from China Medical University, Taichung, Taiwan. After successfully completing his internship and residency, Prof. Tsai went on to pursue his academic research interests as a Research Fellow in leading institutions overseas including: the University of Sydney, Australia, where he obtained his Master of Medicine degree; Virginia University, USA; and at Utano National Hospital, Kyoto, Japan.
To date, Prof. Tsai has contributed more than 60 peer-review papers in the field of neuroscience to the international scientific and medical community.
Prof. Tsai is an office-bearer and member of many distinguished professional societies and organizations. He is President of the Asian and Oceanian Association of Neurology, as well as being Past President of the Taiwan Neurological Society, where he is currently Chief Supervisor and National Delegate.
Werner Hacke, Germany
Professor Hacke is Professor and Chairman of the Department of Neurology at Ruprecht-Karls-Universität Heidelberg, Germany.
He has BSc in Psychology 1972 (Dipl.-Psych., MD and PhD (Habilitation)His main research and clinical interests are Neurological Critical Care, Interventional Stroke Therapy, Stroke Prevention and Neuropsychology.
Professor Hacke is currently, Chairman Steering Committee SPACE II, Member Executive Committee ROCKET AF, Co-Chair NEST III, Co Chair RIVER 3 and Chair Executive Committee ECASS 4
He was the founding President of the Europe Stroke Organization and currently the first Vice President of the World Federation of Neurology.
Sam Berkovic, Australia
Sam Berkovic is Laureate Professor in the Department of Medicine, University of Melbourne. He is a clinical neurologist and clinical researcher with strong basic science collaborations. His group, together with molecular genetic collaborators in Adelaide and Germany, discovered the first epilepsy gene fin 1995 and subsequently have been involved the discovery of many of the known epilepsy genes. This has changed the conceptualisation of the causes of epilepsy and is having a major impact on epilepsy research, and on strategies for diagnosis and development of new treatments. He was elected a Fellow of the Royal Society (London) in 2007.
Helmut Butzkueven, Australia
H Butzkueven is joint director of the Multiple Sclerosis Service at the Royal Melbourne Hospital and Director of the MS service at Box Hill Hospital, both in Melbourne, Australia. He is an Associate Professor in the Department of Medicine, University of Melbourne and Deputy Director of the Melbourne Brain Centre at the Royal Melbourne Hospital.
The research interests of his group focus on two areas of Multiple Sclerosis Research.
In the Academic Centre's MS laboratory, the core focus is
-development of new biomarkers for axonal degeneration in MS
-understanding the effects of MS risk genes, in particular assessment of gene expression and splicing differences in patients with MS and healthy control subjects in areas of known genetic risk.
In the Melbourne Brain Centre at the Royal Melbourne Hospital,
H Butzkueven is the Chairman of the MSBase Foundation (www.msbase.org) providing a seminal contribution to this global online MS cohort study with more than 18700 patients enrolled (64 centres, 27 countries), and more than 100,000 years of patient follow up. Key current projects include development of methodologies for running comparative outcomes trials using registry data, and assessment and refinement of methods to detect disability progression in MS.
Stephen Davis, Australia
Professor Stephen Davis is the inaugural Professor of Translational Neuroscience at the University of Melbourne. He is based at the Royal Melbourne Hospital (RMH) where he is the Director of Neurosciences and Continuing Care, Director of Neurology and Director of the Melbourne Brain Centre (MBC) at the RMH. The MBC at RMH is funded a Centre of Research Excellence (CRE) grant from the NHMRC.
Stephen is the President-Elect of the World Stroke Organization and Co-Chair of the World Stroke Academy. He is the immediate past-President of the Australian and New Zealand Association of Neurologists (ANZAN) and a past-President of the Stroke Society of Australasia. He was the first Co-chair of the Australasian Stroke Trials network and has extensive experience in stroke trials. He is the Co-Chair, with Geoffrey Donnan, of Neuroscience Trials Australia (NTA) and a trustee of the RMH Neuroscience Foundation since its formation in 1992.
Stephen was the 2011 recipient of the William Feinberg Award from the American Stroke Association and the Bethlehem Griffiths Research Foundation medal. He is the joint recipient of an NHMRC program grant in stroke, has co-authored 3 books, numerous book chapters, and over 300 peer-reviewed papers.
Stephen's major research interests involve clinical trials in stroke and the use of neuroimaging, particularly multimodal MRI, in the selection of acute stroke treatments. He is the Co-PI with Geoffrey Donnan of the EXTEND trial, a stroke trial aimed at extending the time window for thrombolysis using MRI in treatment selection.
Patrick Kwan, Australia
Professor Patrick Kwan is Chair of Neurology at the University of Melbourne, Royal Melbourne Hospital, Australia, and Associate Consultant at the Prince of Wales Hospital, Hong Kong. He has published widely on the outcomes of epilepsy and pharmacology of antiepileptic drugs. His other research interests include the mechanisms of drug resistance, co-morbidities, genetics and pharmacogenomics of epilepsy. He serves on the editorial boards of a number of epilepsy journals. He is currently President of the Hong Kong Epilepsy Society, treasurer of the ILAE Commission on Therapeutic Strategies, and chair of the CAOA Research Task Force, and was chair of the task force for the definition of drug-resistant epilepsy.
Terence O'Brien, Australia
Terence O'Brien (MBBS Melb. MD Melb. FRACP) is The James Stewart Professor of Medicine and Head of The Department of Medicine, The Royal Melbourne Hospitals, and consultant neurologist at The Royal Melbourne Hospital, Victoria, Australia. He leads a large translational research team undertaking both basic studies, involving animal models, and clinical studies. He is a specialist in neurology and clinical pharmacology, with particular expertise in epileptology, anti-epileptic drugs and in-vivo imaging in animal models and humans. He did his clinical and research training at St. Vincent's and Royal Melbourne Hospitals in Melbourne, and then the Mayo Clinic, Rochester, Minnesota, USA (1995-1998). He has published over 177 peer-reviewed original papers in leading neurological, pharmacological and imaging journals, 25 other publications and over 500 abstracts.
Steve Reddell, Australia
Stephen Reddel is a staff specialist neurologist at Concord Repatriation & General Hospital Sydney, and consultant neurologist at the Brain & Mind Research Institute, University of Sydney. He trained in neurology at Royal Prince Alfred Hospital, Sydney, and at the Radcliffe Infirmary, Oxford, and has a PhD in the immunology of the Anti-Phospholipid Syndrome.
He runs clinics in neuroimmunology, myasthenia gravis, neurogenetics, and other bits and pieces. He has research interests in myasthenia gravis, examining the function of anti-MuSK antibodies and the homeostasis of the neuromuscular junction; and in neurogenetics including the muscular dystrophies and inherited neuropathies.
Elsdon Storey, Australia
Professor Storey was appointed as Professor of Neuroscience at Monash University (Alfred Hospital campus), Director of the Van Cleef Roet Centre for Nervous Diseases, and Head of the Neurology Unit, Alfred Hospital in 1996. He commenced clinical neurology training in the UK and completed it in Melbourne, before undertaking postdoctoral studies in the neurochemistry of Huntington's disease at Massachusetts General Hospital, where his interests in neurogenetics and behavioural neurology were kindled. He returned to Australia in 1991 to work on Alzheimer's disease with Professor Colin Masters. He started neurogenetics clinics at RMH, St. Vincent's and the Alfred, and has been Neurologist to the Memory Clinic at Caulfield Hospital since 1997. He is Neurology Co-Editor of the Journal of Clinical Neuroscience.
Bernard Yan, Australia
Bernard Yan currently holds dual clinical appointments at the Royal Melbourne Hospital (RMH) as Neurointerventionist and Neurologist. He is an associate professor of the University of Melbourne.
He is the current director of Telestroke Service at RMH.
His key administrative appointments include Chair of the Australasian Stroke Trials Network (ASTN), Treasurer of the Stroke Society of Australasia (SSA) and Council member of the Australia and New Zealand Society of Neurologists (ANZAN).
He is the founder of the University of Melbourne (UoM) Neurology Subspecialty Training Course (NSTC) in China. The training course has been operational since 2010 and is now in its second year. He is a research supervisor to research fellows from UoM Department of Medicine and also to overseas neurology research fellows from China.
He is the principal investigator and on the steering committee of major international stroke trials. He is on the steering committee of EXTEND (Extending the Time for Thrombolysis in Emergency Neurological Deficits), IMS 3 (Interventional Management of Stroke Study 3) and INSPIRE (International Stroke Perfusion Imaging Registry). He is also the principal investigator (Australia) of the Intra-arterial Plasmin for Ischaemic Stroke Study. His research interests include the development of novel devices for the treatment of acute stroke and aneurysms. He is the co-inventor of endovascular devices which have received NHMRC (National Health and Research Council, Australia) grants. A major focus of his research is in the translation of broadband technology to the delivery of telestroke services to rural areas (Telestroke Service).